Our Story
Founded in 2020 and headquartered in Singapore, BMS-Science Pte Ltd was established to address a critical need in the ASEAN R&D ecosystem: the transition from laboratory concepts to operational excellence.
We specialize in providing high-level consultancy for Small and Medium Enterprises (SMEs) and large research institutions, ensuring that every project is built on a foundation of scientific integrity and strategic foresight.
Our Philosophy
We believe that research is only as good as the methodology behind it.
Open communication and clear data tracking are at the heart of our client partnerships.
Our goal is to make advanced R&D frameworks accessible to growing companies, not just industry giants.
Founding Director, Sr Consultant
Originally trained in Health Biotechnology and Immunology, Dr. Bertin-Maghit has been a driving force in biomedical research since the early 2000s. His career spans the biotech industry, academia, and private healthcare systems across multiple countries, with a focus on autoimmune diseases and the development of novel therapeutics for cancer and infectious diseases.
With over a decade of experience managing research activities in Southeast Asia, Sebastien is an expert in navigating the regional R&D landscape. Notably, he designed and implemented a comprehensive basic and clinical research framework for Vietnam's leading hospital network, demonstrating his ability to build world-class scientific infrastructure from the ground up. Since 2023, he joined the #1 and most prestigious university in Thailand in a program about Integrated Innovation.
Senior Consultant, Scientific Advisor
A globally recognized scientist with over 25 years of experience in biomedical R&D, Dr. Maxime Herve specializes in bridging the gap between clinical research and consumer healthcare innovation. Trained at the prestigious Pasteur Institute in France, he earned his PhD in Immunology and Parasitology following pioneering work in West Africa on vaccine development for Schistosomiasis.
Throughout his career spanning four continents, Maxime has led high-impact projects in diverse settings—from molecular immunology research in New York hospitals to pharmaceutical development for infectious diseases in Singapore. His transition to the private sector saw the successful creation of specialized natural product lines for pain and inflammation. Currently, he focuses on the intersection of public health and global change, advising on the health impacts of climate change and the evolution of personal healthcare management.